(Q42164961)

17 October 2017

Effect of insulin therapy on endothelium-dependent dilation in type 2 diabetes mellitus (English)

1 reference

17 October 2017

0 references

1 reference

1 reference

1 reference

Hannes Gaenzer

1

1 reference

17 October 2017

Günther Neumayr

2

1 reference

17 October 2017

Peter Marschang

3

1 reference

17 October 2017

Wolfgang Sturm

4

1 reference

17 October 2017

Monika Lechleitner

5

1 reference

17 October 2017

Bernhard Föger

6

1 reference

17 October 2017

Rudolf Kirchmair

7

1 reference

17 October 2017

Josef Patsch

8

1 reference

17 October 2017

language of work or name

English

0 references

publication date

1 February 2002

1 reference

American Journal of Cardiology

17 October 2017

1 reference

17 October 2017

89

1 reference

17 October 2017

4

1 reference

17 October 2017

431-434

1 reference

Vascular thrombosis in type II diabetes mellitus

17 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902266-4

Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902266-4

Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902266-4

Insulin and risk of cardiovascular disease: a meta-analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902266-4

Improved endothelial function with metformin in type 2 diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902266-4

Ciprofibrate therapy improves endothelial function and reduces postprandial lipemia and oxidative stress in type 2 diabetes mellitus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902266-4

Effect of oral vitamin E (alpha-tocopherol) supplementation on vascular endothelial function in Type 2 diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902266-4

Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902266-4

Insulin therapy improves endothelial function in type 2 diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902266-4

Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902266-4

Preserved endothelial function in IDDM patients, but not in NIDDM patients, compared with healthy subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902266-4

Impaired endothelium-dependent vasodilation in type 2 diabetes. Relation to LDL size, oxidized LDL, and antioxidants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902266-4

Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with type 2 diabetes in association with insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902266-4

Impaired endothelium-dependent and independent dilatation of forearm resistance arteries in men with diet-treated non-insulin-dependent diabetes: role of dyslipidaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902266-4

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902266-4

Endothelium-dependent flow-mediated vasodilation in the postprandial state in type 2 diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902266-4

Endothelial dysfunction and pathogenesis of diabetic angiopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902266-4

Dyslipoproteinaemia and hyperoxidative stress in the pathogenesis of endothelial dysfunction in non-insulin dependent diabetes mellitus: an hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902266-4

Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902266-4

Activation of protein kinase C by elevation of glucose concentration: proposal for a mechanism in the development of diabetic vascular complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902266-4

Hemoglobin-AGE: a circulating marker of advanced glycosylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902266-4

Lipid advanced glycosylation: pathway for lipid oxidation in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902266-4

Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902266-4

Ascorbate restores endothelium-dependent vasodilation impaired by acute hyperglycemia in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902266-4

NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902266-4

Novel inflammatory markers of coronary risk: theory versus practice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902266-4

C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902266-4

Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902266-4

10.1016/S0002-9149(01)02266-4

7 January 2021

Identifiers

DOI

1 reference

release_lboj5rhbmjfphpze4qiuxdbgue

17 October 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/lboj5rhbmjfphpze4qiuxdbgue

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference